For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
GP encouraged by Wellington mental health programme
GP encouraged by Wellington mental health programme

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 8 November 2024.
From Zach: I’ve done a few stories about mental health this year, making it difficult to pick just one to highlight for Summer Hiatus. But I was really inspired by what the team at Whakamātūtū are aiming to achieve in their holistic approach, which incorporates wellbeing model, Te Whare Tapa Whā, and aims to work within the parameters of an overstretched and underfunded primary care workforce to ensure people can access the care they need
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.